CTOs on the Move

Sapience Therapeutics

www.sapiencetherapeutics.com

 
Sapience Therapeutics is a preclinical-stage biotechnology company focused on advancing novel therapeutics for major unmet medical needs, particularly high mortality cancers. Our drug development program involves translating science into novel therapies, and our initial goal is to develop a first-in-class treatment for glioblastoma multiforme (GBM), which is the most severe and deadly form of brain cancer.
  • Number of Employees: 0-25
  • Annual Revenue: $0-1 Million

Executives

Name Title Contact Details

Funding

Sapience Therapeutics raised $22.5M on 07/13/2016

Similar Companies

Vium

Vium is the first company to create a living informatics platform for preclinical in vivo drug research.

Rubedo Life Sciences

Rubedo Life Sciences is an anti-aging company based in the Silicon Valley, California.

Innovate Biopharmaceuticals

Innovate is a clinical stage biotechnology company developing novel medicines for gastroenterological disorders.

Point Biopharma

POINT Biopharma develops next-generation radioligand therapies for the treatment of cancer

Quintessence Biosciences Inc

Quintessence Biosciences Inc is a Madison, WI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.